What products does Orchard Pharmaceuticals offer?

Orchard Pharmaceuticals specializes in developing and providing gene therapies for rare diseases, particularly those related to inherited disorders. The company focuses on conditions such as hemophilia and other genetic disorders, aiming to offer innovative treatments that can significantly improve the quality of life for affected individuals. One of their notable products is called OTL-103, which is designed for the treatment of adenosine deaminase deficiency severe combined immunodeficiency, also known as ADA-SCID, a rare genetic disorder. Another important therapy in their pipeline is OTL-201, targeting mucopolysaccharidosis type I, which is a metabolic disorder. Orchard Pharmaceuticals is committed to advancing its product offerings through ongoing research and development, as well as partnering with other organizations to expand the range of therapies available to patients. For specific details regarding their products and therapeutic areas, it would be beneficial to visit their official website, where they provide up-to-date information and resources. This approach ensures that anyone interested can access the most current insights into Orchard's offerings and initiatives.